- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Results
3
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
3 companies
Consun Pharmaceutical Group
Market Cap: HK$8.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$10.62
7D
6.3%
1Y
59.5%
Shanghai Henlius Biotech
Market Cap: HK$25.4b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$46.65
7D
10.8%
1Y
147.6%
Uni-Bio Science Group
Market Cap: HK$507.6m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.085
7D
4.9%
1Y
14.9%